ATARA Biotherapeutics (ATRA) Misses Q1 EPS by 35c
Tweet
Share
E-mailGet Alerts ATRA Hot Sheet
Join SI Premium – FREE
ATARA Biotherapeutics (NASDAQ: ATRA) reported Q1 EPS of ($0.72), $0.35 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $1.23 million versus the consensus estimate of $32.01 million.
For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Activist Jana Partners calls for Six Flags sale - WSJ
- Worthington Industries (WOR) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
